Pfizer targeted by anti-advertising campaign
A USA-based pressure-group that campaigns against direct advertising by pharmaceutical companies has attacked Pfizer for running print advertisements for the erectile dysfunction drug Viagra (sildenafil citrate). The advertisements, which appeared in the Wall Street Journal in the run up to the new year, featured a handsome over-40 man grinning at the camera with the tagline: "What are you doing New Year's eve?" Michael Weinstein, president of the AIDS Healthcare Foundation, condemned the adverts saying "sending this reckless message contribute[s] to the spread of sexually-transmitted diseases."
Mr Weinstein in a June 2005 statement, congratulated Bristol-Myers Squibb for suspending its direct to customer advertising for a year.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze